NEXT Oncology is a clinical research site located in San Antonio, Texas, United States 78229.
Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
NEXT Oncology has participated in 143 clinical trials with 70 currently active.
Therapeutic areas: Gastrointestinal Tumors, Colorectal Adenocarcinomas, Gastric Adenocarcinomas.
Sponsors: Pfizer, Bolt Biotherapeutics, Inc., Daiichi Sankyo.
Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NEXT Oncology has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT Oncology has 143 clinical trials on record, with 70 currently active. Their work covers Gastrointestinal Tumors, Colorectal Adenocarcinomas, Gastric Adenocarcinomas.
NEXT Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.